scispace - formally typeset
Z

Zheng Dong

Researcher at Charlie Norwood VA Medical Center

Publications -  336
Citations -  29827

Zheng Dong is an academic researcher from Charlie Norwood VA Medical Center. The author has contributed to research in topics: Kidney & Acute kidney injury. The author has an hindex of 70, co-authored 283 publications receiving 24123 citations. Previous affiliations of Zheng Dong include Veterans Health Administration & Yonsei University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

TL;DR: Examination of tumor-bearing animals and identification of novel renoprotective strategies that do not diminish the anticancer efficacy of cisplatin are essential to the development of clinically applicable interventions.
Journal ArticleDOI

Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models

TL;DR: In vivo analysis revealed that mitochondrial fragmentation also occurred in proximal tubular cells in mice during renal ischemia/reperfusion and cisplatin-induced nephrotoxicity, and was identified as what is believed to be a novel mechanism contributing to mitochondrial damage and apoptosis in vivo in mouse models of disease.
Journal ArticleDOI

Regulated Cell Death in AKI

TL;DR: Combination therapy targeting multiple cell-death pathways may, therefore, provide maximal therapeutic benefits in AKI.